Inari Medical Inc (NARI)
41.20
+0.52
(+1.28%)
USD |
NASDAQ |
Sep 27, 16:00
41.14
-0.06
(-0.16%)
After-Hours: 20:00
Inari Medical SG&A Expense (Annual): 361.06M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 361.06M |
December 31, 2022 | 292.84M |
December 31, 2021 | 190.36M |
Date | Value |
---|---|
December 31, 2020 | 89.75M |
December 31, 2019 | 37.20M |
December 31, 2018 | 10.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
37.20M
Minimum
2019
361.06M
Maximum
2023
194.24M
Average
190.36M
Median
2021
SG&A Expense (Annual) Benchmarks
Nevro Corp | 334.70M |
Inspire Medical Systems Inc | 451.96M |
Axonics Inc | 235.32M |
Electromed Inc | 34.49M |
Myomo Inc | 18.78M |